ENSTILAR

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, United Kingdom, United States

Active ingredients

The drug ENSTILAR contains a combination of these active pharmaceutical ingredients (APIs):

1 Calcipotriol UNII S7499TYY6G - CALCIPOTRIENE MONOHYDRATE

Calcipotriol is a derivative of vitamin D for topical use on psoriasis. It probably works by suppressing keratinization. Advantage of substance or absence of odor and non-coloring of clothing. Read about Calcipotriol

2 Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ENSTILAR Foam	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D05AX52	Calcipotriol, combinations	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11091R
Country: CA	Health Products and Food Branch	Identifier(s): 02457393
Country: EE	Ravimiamet	Identifier(s): 1680050, 1680061
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 80896
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 561259, 579406
Country: FR	Base de données publique des médicaments	Identifier(s): 67347855
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 326154, 351733, 380788, 381332, 387248
Country: HK	Department of Health Drug Office	Identifier(s): 66143
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-453098022
Country: IE	Health Products Regulatory Authority	Identifier(s): 43072, 43073
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8625
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1075861, 1080064
Country: MT	Medicines Authority	Identifier(s): MA024/01101
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 133329
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 18324
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100339770
Country: US	FDA, National Drug Code	Identifier(s): 50222-302